Concepedia

Khoan Vu

KV

11

Publications

1.1K

Citations

11

H-Index

2014

Active since

Affiliations

University of California, San Francisco(Current)

Washington University in St. Louis

Cleveland Clinic

UCSF Helen Diller Family Comprehensive Cancer Center

Stanford University

Khoan Vu is an author at University of California, San Francisco specializing in immunology, pathology, and medicine.

ORCID

Top concepts

Publications per year

2014–2022

11

Publications

11

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Loretta J. Nastoupil, Michael D. Jain, Lei Feng et al. · Journal of Clinical Oncology · 2020 · 752 citations · Full text

Experience with Axicabtagene Ciloleucel (Axi-cel) in Patients with Secondary CNS Involvement: Results from the US Lymphoma CAR T Consortium

N. Nora Bennani, Matthew J. Maurer, Loretta J. Nastoupil et al. · Blood · 2019 · 59 citations

T Cell–Replete Peripheral Blood Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide Results in Outcomes Similar to Transplantation from Traditionally Matched Donors in Active Disease Acute Myeloid Leukemia

Joan How, Michael Slade, Khoan Vu et al. · Biology of Blood and Marrow Transplantation · 2017 · 42 citations · Full text

Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis

Steven M. Bair, Lauren E. Strelec, Tatyana Feldman et al. · The Oncologist · 2018 · 40 citations · Full text

Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study

Khoan Vu, Chi-Heng Wu, Chen‐Yen Yang et al. · Clinical Cancer Research · 2019 · 38 citations · Full text

Rows per page

1–5 of 11